natureindex.com

Sitemap

Sign up

Nature Index

  • Home
  • News
    • News home
    • Listings
    • News
    • Comment
    • Nature Index 360°
    • Q&A
    • Dataviz
    • News archive
  • Current Index
    • Institution tables
    • Institutions A-Z
    • Research highlights
    • Country/territory tables
    • Articles
    • Collaborations
    • City maps
    • Custom tables
    • Custom graphs
  • Annual tables
    • 2020 tables
    • 2019 tables
    • 2018 tables
    • 2017 tables
    • 2016 tables
  • Supplements
    • Nature Index supplements
    • Nature Index 2020 Artificial Intelligence
    • Nature Index 2020 Germany
    • Nature Index 2020 Science Cities
    • Nature Index 2020 South Korea
    • Nature Index 2020 Cancer
    • Nature Index 2019 Materials Science
    • Nature Index 2019 Collaboration and Big Science
    • Nature Index 2019 Young Universities
    • Nature Index 2019 Biomedical Sciences
    • Nature Index 2019 Japan
    • Nature Index 2018 China
    • Nature Index 2018 Science Cities
    • Nature Index 2018 Rising Stars
    • Nature Index 2018 Earth and Environmental Sciences
    • Nature Index 2018 Japan
    • Nature Index 2017 Science Inc.
    • Nature Index 2017 United States
    • Nature Index 2017 Science Cities
    • Nature Index 2017 Saudi Arabia
    • Nature Index 2017 Innovation
    • Nature Index 2017 China
    • Nature Index 2017 Japan
    • Nature Index 2016 Collaborations
    • Nature Index 2016 Australia and New Zealand
    • Nature Index 2016 Rising Stars
    • Nature Index 2016 Saudi Arabia
    • Nature Index 2016 Japan
    • Custom reports
  • Client services
    • Client services
    • 2020 Brochure
  • About
    • FAQ
    • Glossary of terms
    • Knowledge base
    • Nature Index journals
    • Journal selection
    • Using the Index
    • Newsletter signup
  1. Home
  2. Institution outputs
  3. Paradigm Therapeutics Ltd., United Kingdom (UK)

Paradigm Therapeutics Ltd.

United Kingdom (UK)

  • Research
  • Relationships

1 December 2019 - 30 November 2020

No articles found. Paradigm Therapeutics Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Takeda Pharmaceutical Company Limited
↳ Paradigm Therapeutics Ltd.
ARIAD Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Oncology Drug Discovery Unit (DDU)
Nihon Pharmaceutical Co., Ltd.
Nycomed Pharma Private Limited
Shire
Dyax Corp.
Dyax SA
Shire plc
Shire Human Genetic Therapies Inc.
Shire Pharmaceuticals, Inc.
Shire, US
Shire Austria GmbH
Takeda California, Inc.
Takeda Cambridge Ltd.
Takeda Development Centre Europe Ltd. (TDC Europe)
Takeda Giken Service Ltd.
Takeda Pharmaceutical Shonan Institute
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Cambridge, Massachusetts
Takeda Global Research & Development Center, Inc.
Takeda Vaccines, Inc.
Takeda Ventures, Inc. - UK

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free

Nature Index 2020 Germany

Nature Index 2020 Germany

Germany's position as a research giant is defined by its strong and steady science funding and long-term investment in basic research. But although national science organizations are thriving under funding certainty, there are concerns that some universities will be left behind.

Access free

Sponsored content

  • Discover the latest research from Ireland

Contact us
Follow us on Twitter
Follow us on Facebook

Research highlights of partners

Protein production with laser precision

Okayama University

23 Jun 2017

Future of fuel is up in the air

University of Chinese Academy of Sciences (UCAS)

17 Nov 2017

The shape of things to come in drug design

Ireland

27 Feb 2018

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up

Useful links

  • FAQ

  • User tips

  • The Nature Index journals

Advertisement

  • FAQ
  • Client Services
  • Institution outputs
  • Country outputs
  • News
  • Supplements
  • Privacy policy
  • California Privacy Statement
  • Use of cookies
  • Manage cookies/Do Not Sell My Info
  • Legal notice
  • Terms
  • Nature.com
  • Nature News
  • Nature Careers
  • Nature Asia-Pacific

Springer Nature

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER